The low-key event hosted by the Academy of Motion Pictures Arts and Science's felt on par with the Met Gala: Jennifer ...

Now, we already know that Johnny Depp and Vanessa Paradis ‘ daughter Lily-Rose Depp is her supermodel mom’s lookalike, but now, Lily-Rose is separating from her and her mom’s usual style and going ...

She’s dripping in crystals. On Saturday, Blake Lively, 37, attended the LACMA Art + Film Gala 2024 in a sumptuous diamond chainmail dress from Tamara Ralph that showed off tons of skin.

A reboot of Sylvester Stallone’s 1993 thriller ‘Cliffhanger’ will star Lily James and Pierce Brosnan Rocket Science;StudioCanal/Shutterstock Lily James is ...

Lily James and Pierce Brosnan are set to star in a new reimagining of the classic action pic Cliffhanger with Jaume Collet-Serra directing. The project is a Rocket Science production in ...

(AP Photo/Peter Morgan) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] NEW YORK (AP) — U.S. stock indexes edged lower Wednesday after drops for Eli Lilly and chip companies ...

Please go ahead. Thank you, Paul, and good morning, everybody. Thanks for joining us for Eli Lilly and Company's Q3 2024 earnings call. I'm Joe Fletcher, Senior Vice President of Investor Relations.

Eli Lilly on Wednesday fell short of profit and revenue expectations for the third quarter, weighed down by disappointing sales of its blockbuster weight loss drug Zepbound and diabetes treatment ...

Copyright 2024 The Associated Press. All Rights Reserved. FILE - This April 26, 2017 file photo shows the Eli Lilly & Co. corporate headquarters in Indianapolis. (AP ...

AJ Mast / Bloomberg via Getty Images Eli Lilly (LLY) shares tumbled 12% at the opening bell Wednesday after its third-quarter results fell well short of analysts' estimates and it lowered its full ...

Drug maker Eli Lilly’s share price plunged Wednesday morning after the company reported worse third-quarter results than expected, especially in its weight-loss drug division, registering a rare ...

Eli Lilly reported Q3 revenue and earnings that fell short of analysts' expectations. Mounjaro and Zepbound faced challenges as U.S. wholesalers reduced inventories of the drugs. The bull case for ...